Can You Change DNA From Male to Female?

Delve into the scientific realities of altering an individual’s core biological blueprint and the distinctions between genetic makeup and identity.

No technology exists that can rewrite every cell in a living human body from XY to XX or vice versa. Your sex chromosomes are copied into trillions of cells during development, and there is no method to reach them all and swap one chromosome for another. But the question is more interesting than a flat “no” suggests, because the relationship between chromosomal DNA and biological sex involves layers that most people never hear about. A single gene on the Y chromosome acts as the master switch, natural mutations can override it entirely, hormone therapy shifts how genes are read without changing the sequence, and researchers have already eliminated sex chromosomes in lab cells using gene-editing tools.

What Actually Makes DNA “Male”

People often think of the Y chromosome as the thing that makes someone male, but the Y chromosome carries relatively few genes. The heavy lifting is done by one gene in particular: SRY, short for “sex-determining region Y.” SRY sits near the tip of the Y chromosome’s short arm, and its job is to trigger a cascade of signals that turn an undifferentiated embryonic gonad into a testis. Without SRY firing at the right time during development, that gonad will default toward becoming an ovary instead.

The evidence that SRY is the master switch comes from several lines of research. Some XY individuals who are phenotypically female have been found to carry mutations or deletions in SRY that prevent it from functioning. When researchers tested these individuals’ DNA, they found the rest of the Y chromosome was intact, but the broken SRY gene was enough to derail male development entirely. This tells us something important: “male DNA” is not really about having a Y chromosome per se. It is about whether SRY works and whether the downstream genes it activates respond properly.

Once the gonads form, they produce hormones that shape the rest of sexual development. But the story does not end there. In females, one of the two X chromosomes in each cell is silenced early in development through a process involving a molecule called XIST. This silencing balances gene dosage between XX and XY individuals, and it is maintained throughout life. So even within “female DNA,” only one X chromosome is active in any given cell. The genetic picture is already more complicated than the simple XX-versus-XY shorthand.

When XY DNA Produces a Female Body

One of the clearest demonstrations that you cannot reduce sex to a chromosome pair is Swyer syndrome. People with Swyer syndrome have a 46,XY karyotype, meaning they carry a Y chromosome in every cell, yet they develop female external anatomy, a uterus, and streak gonads that never become functional testes or ovaries. The cause is typically a mutation or deletion in SRY that prevents it from initiating testis formation.

Case reports illustrate how varied these mutations can be. In one case, a single nucleotide insertion at a specific position in SRY was enough to cause complete sex reversal in a 46,XY individual. In another, a microdeletion in SRY was detected in a girl who presented with delayed puberty and was eventually diagnosed with the condition. These individuals did not have their DNA “changed” from male to female. Their DNA was XY from the start, but a broken switch meant the male developmental pathway never turned on.

The reverse also happens. Genes like FOXL2 actively maintain ovarian identity throughout life, and when FOXL2 is lost in mouse experiments, testis-associated genes like SOX9 become activated even in cells that were following an ovarian program. This means gonadal sex is not just set once during embryonic development and then locked in permanently. There is ongoing maintenance, and disrupting the maintenance genes can push cells toward the other sex’s developmental program. The supporting cell lineage in gonads appears to be a site of direct antagonism between SOX9, which drives testis identity, and FOXL2, which maintains ovarian identity.

What Hormone Therapy Changes at the Molecular Level

Gender-affirming hormone therapy does not alter the DNA sequence. A trans woman taking estrogen still carries a Y chromosome, and a trans man taking testosterone still carries two X chromosomes. But hormones do something subtler: they change how DNA is read. Researchers have found that hormone therapy shifts patterns of DNA methylation, the chemical tags that sit on top of DNA and help determine which genes are turned on or off in a given cell.

In a study tracking people over the course of feminizing and masculinizing hormone therapy, researchers identified thousands of sites across the genome where methylation levels changed. The direction of those changes was consistent: methylation patterns shifted toward those typically seen in the opposite sex. The study also noted enrichment of changes at sites associated with puberty-related methylation shifts, suggesting that hormone therapy partially recapitulates what happens during natural pubertal development.

These epigenetic changes have functional consequences. Specific immune-related genes respond differently depending on the direction of therapy. For instance, a methylation site in the promoter of IL-21, a gene involved in immune signaling, gained methylation after a year of masculinizing therapy but lost it after a year of feminizing therapy. Another study found that after six months of testosterone treatment, methylation at the estrogen receptor gene promoter increased in trans men, and the difference in methylation between trans men and trans women at that site disappeared, with both groups settling at a level intermediate between cisgender men and cisgender women.

To put this in perspective, roughly a third of all human genes show sex-biased expression in at least one tissue type. Much of that difference is driven by hormones rather than by the sex chromosomes directly. In the brain, for example, mouse research has shown that estrogen receptor alpha orchestrates sex differences in both neuron types and gene expression programs, meaning hormones are actively writing the instructions that create sex-differentiated tissues. So while hormone therapy cannot touch the DNA letters themselves, it rewrites a surprisingly large part of how those letters are interpreted.

Gene Editing and Chromosome Elimination in the Lab

CRISPR, the gene-editing tool that has transformed molecular biology, has been used to selectively eliminate an entire sex chromosome from cells. Researchers designed guide molecules that targeted sites found in many copies on a specific chromosome, and by making cuts at all those sites simultaneously, they caused the targeted chromosome to be lost. This worked in cultured cells, in embryos, and even in living tissue in mice.

That is a proof of concept, not a therapy. Eliminating a chromosome from a dish of cells is very different from eliminating it from every relevant cell in an adult body. The delivery problem alone is staggering: you would need to get the editing machinery into trillions of cells across dozens of tissue types, all while avoiding damage to the rest of the genome. And even if you removed the Y chromosome, you would still need to add a second functional X chromosome to replace it, which is a separate challenge entirely.

A different approach made headlines when a Japanese research group led by Katsuhiko Hayashi produced mice with two biological fathers. The team took male stem cells (XY), grew them in culture until a rare event occurred where a cell spontaneously lost its Y chromosome, then experimentally promoted duplication of the remaining X chromosome. This converted XY stem cells into XX stem cells, which were then coaxed into becoming egg cells. Those eggs were fertilized and some of the resulting mice survived to adulthood. The procedure is extraordinarily complex, inefficient, and currently limited to mice, but it demonstrated that cellular sex can be converted under controlled laboratory conditions.

The Y Chromosome You Lose With Age

Here is a twist most people do not expect: many men are already losing their Y chromosomes naturally. As men age, some of their blood cells shed the Y chromosome during cell division. This condition, called mosaic loss of Y (mLOY), was once dismissed as a harmless byproduct of aging. It is now recognized as the most commonly acquired somatic mutation in males, and it has been linked to cardiovascular disease, neurodegeneration, and various cancers.

Research has shown that the loss is not merely cosmetic at the cellular level. When blood cells lose their Y chromosome, it appears to activate immune checkpoint pathways and impair the body’s ability to clear senescent cells, contributing to conditions like kidney disease. These men have not “become female” in any meaningful sense. Their bone, muscle, brain, and other tissues still carry XY chromosomes. But their blood cells are a mosaic, some XY, some just X. It is a natural example of chromosomal sex changing in a subset of cells, and it shows that even the genome is not as permanent as we tend to imagine.

Mixed Chromosomes After Bone Marrow Transplants

Another real-world scenario in which a person carries DNA of the opposite chromosomal sex is a sex-mismatched bone marrow transplant. When a woman receives a bone marrow transplant from a male donor, her blood-forming cells are replaced by the donor’s XY cells. Studies have confirmed that in these cases, Y-chromosome DNA becomes the dominant type of cell-free DNA circulating in the recipient’s plasma. Donor-derived DNA has even been detected in the urine of female recipients who received transplants from male donors.

The chimerism can persist for years. Analysis of male patients who received bone marrow from female donors detected residual Y-chromosome sequences in some samples out to 72 months post-transplant, reflecting the gradual but sometimes incomplete replacement of host blood cells by donor cells. These individuals are walking chimeras, carrying two different chromosomal sex types in different tissues. Their structural organs retain the original karyotype, while their blood system runs on the other. It is not a full chromosomal sex change, but it is a genuine blending of male and female DNA within one body.

Why Some Animals Can Do What Humans Cannot

If you look beyond mammals, sex reversal at the genetic level is not hypothetical at all. In many fish, amphibians, and some reptiles, environmental temperature can override chromosomal sex determination, producing individuals whose physical sex does not match their genotype. In fish species with temperature-dependent sex determination, even a shift of one to two degrees Celsius can push the sex ratio from balanced to heavily male-biased.

The bearded dragon (Pogona vitticeps) is a well-studied example among reptiles. At high incubation temperatures, genetically male embryos develop as functional females. Researchers examining these sex-reversed lizards found a high frequency of ovotestes, structures containing a mix of male and female tissue. The ovotestes appear to reflect a period during development when male and female sex-determination pathways are actively fighting each other for control of the gonad. The DNA in these lizards has not changed. Their genotype is still male. But their phenotype, their functional reproductive sex, has been overridden by environmental signals.

Mammals lack this flexibility because our sex determination pathway is more rigidly committed to the SRY-triggered cascade and because our internal body temperature does not fluctuate with the environment. The mammalian system relies heavily on a genetic switch rather than an environmental one, which makes chromosomal sex reversal far harder to achieve without intervening at the molecular level.

Chromosome Variations That Blur the Binary

The standard framing of XX and XY does not capture the full range of human chromosomal variation. Turner syndrome occurs when one of the two sex chromosomes is partially or completely missing, resulting in a 45,X karyotype. People with Turner syndrome are phenotypically female but often face growth disorders, reproductive challenges, and cardiovascular issues. Klinefelter syndrome involves a 47,XXY karyotype, which produces a male phenotype with additional X-linked characteristics. These conditions are not exceedingly rare: Klinefelter syndrome occurs in roughly one in 600 to 1,000 male births.

Forensic and prenatal testing sometimes reveals these variations unexpectedly. The Amelogenin sex test, a standard tool in forensic DNA analysis, has flagged individuals whose chromosomal makeup did not match the expected pattern. In one case review spanning 13 years, three adult males showed signal patterns suggesting a 47,XXY karyotype that had never been clinically diagnosed. Cell-free DNA screening during pregnancy can now detect sex chromosome aneuploidies with high sensitivity, though the positive predictive value varies by condition, ranging from about 21% for Turner syndrome to above 90% for Klinefelter syndrome in one large single-center study.

These variations matter for our question because they show that chromosomal sex is not always a clean binary even before anyone tries to change it. A person with 47,XXY has “male DNA” and “extra female DNA” simultaneously. A person with 45,X has female anatomy built from a single X with no partner chromosome at all. The genome is less tidy on this point than the textbook version suggests.

Why the Y Chromosome Is Not Vanishing

You may have encountered the claim that the Y chromosome is slowly shrinking and will eventually disappear. It is true that the Y chromosome has lost most of the genes it once shared with the X over hundreds of millions of years. But research on both primate Y chromosomes and sex chromosome evolution in other species suggests that the degeneration process is not linear. The genes still remaining on the human Y chromosome appear to be under strong selection pressure to stay, and theoretical models support the idea that the Y is unlikely to vanish entirely in the foreseeable evolutionary future.

That said, some rodent species have already lost their Y chromosome and SRY gene entirely, and they still produce males. They have evolved alternative sex-determining mechanisms. This reminds us that while SRY is the master switch in humans and most other mammals, the broader machinery of sex determination is flexible enough, on evolutionary timescales, to find workarounds. It does not mean humans are likely to evolve away from SRY-based sex determination anytime soon, but it does mean the question of whether DNA can be “male” or “female” without a Y chromosome already has a natural answer in some corners of the mammalian family tree.